
Aptorum Group Limited APM
$ 0.98
1.35%
Annual report 2024
added 01-17-2026
Aptorum Group Limited DSO Ratio 2011-2026 | APM
Annual DSO Ratio Aptorum Group Limited
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | 20.6 | 14.8 | 1.35 | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 20.6 | 1.35 | 12.2 |
DSO Ratio of other stocks in the Biotechnology industry
| Issuer | DSO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Biogen
BIIB
|
57.9 | $ 173.17 | 0.92 % | $ 25.2 B | ||
|
Adagene
ADAG
|
53.8 | $ 2.4 | -3.61 % | $ 135 M | ||
|
Acorda Therapeutics
ACOR
|
48.3 | - | -24.86 % | $ 820 K | ||
|
Alterity Therapeutics Limited
ATHE
|
16.2 K | $ 3.67 | 3.38 % | $ 8.83 B | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
84.7 | - | - | $ 40.3 B | ||
|
Catalyst Biosciences
CBIO
|
3.24 | $ 11.66 | -8.95 % | $ 768 M | ||
|
Midatech Pharma plc
MTP
|
204 | - | -18.52 % | $ 27.3 M | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
2.75 K | - | -1.52 % | $ 24.7 M | ||
|
BioXcel Therapeutics
BTAI
|
16.3 | $ 1.77 | -2.75 % | $ 4.49 M | ||
|
Cellectis S.A.
CLLS
|
94.5 | $ 4.13 | -6.56 % | $ 116 M | ||
|
Ascendis Pharma A/S
ASND
|
132 | $ 233.49 | -0.81 % | $ 5 B | ||
|
Acasti Pharma
ACST
|
1.97 | - | 4.01 % | $ 150 M | ||
|
Arrowhead Pharmaceuticals
ARWR
|
8.75 | $ 67.41 | 0.54 % | $ 9.02 B | ||
|
Compugen Ltd.
CGEN
|
60.8 | $ 2.04 | -2.39 % | $ 183 M | ||
|
Can-Fite BioPharma Ltd.
CANF
|
28.1 | $ 4.36 | -2.46 % | $ 9.49 B | ||
|
Aeterna Zentaris
AEZS
|
146 | - | 5.93 % | $ 314 M | ||
|
AgeX Therapeutics
AGE
|
78.4 | - | -10.17 % | $ 12.2 K | ||
|
Aeglea BioTherapeutics
AGLE
|
216 | - | - | $ 1.01 B | ||
|
Adaptimmune Therapeutics plc
ADAP
|
25 | - | -15.15 % | $ 60.3 M | ||
|
Amphastar Pharmaceuticals
AMPH
|
62.6 | $ 26.57 | 2.51 % | $ 1.29 B | ||
|
Coherus BioSciences
CHRS
|
263 | $ 2.26 | 9.7 % | $ 213 M | ||
|
Amneal Pharmaceuticals
AMRX
|
55.7 | $ 13.59 | 1.46 % | $ 4.2 B | ||
|
AIkido Pharma
AIKI
|
17.9 | - | 1.93 % | $ 17.4 M | ||
|
Albireo Pharma
ALBO
|
14.7 | - | -0.23 % | $ 916 M | ||
|
CureVac N.V.
CVAC
|
13.6 | - | - | $ 867 M | ||
|
Aravive
ARAV
|
16.8 | - | -13.39 % | $ 1.45 M | ||
|
Alpine Immune Sciences
ALPN
|
154 | - | - | $ 2.17 B | ||
|
Celldex Therapeutics
CLDX
|
86.5 | $ 26.72 | 3.09 % | $ 1.72 M | ||
|
Ayala Pharmaceuticals
AYLA
|
61.7 | - | - | $ 7.46 M | ||
|
Aytu BioScience
AYTU
|
150 | $ 2.75 | 1.85 % | $ 17.3 M | ||
|
Arena Pharmaceuticals
ARNA
|
946 | - | -6.81 % | $ 3.04 B | ||
|
Brickell Biotech
BBI
|
254 | - | -5.38 % | $ 6.06 M |